Komori
New Japan Chemical (4406) · InitiativeAdvanced

Renewal of existing production facilities and capital expenditures

First written in FY2017. 4 of 12 entries say "Restated". Latest entry: FY2026.

12entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q2 – FY2020-Q2OtherFY2023-Q2 – FY20252017: 220172018: 220182019: 120192020: 220202021: 120212022: 120222023: 020232024: 120242025: 120252026: 12026
Same theme, other companies
Combined Investment in Manufacturing Facility Expansion and Core System RenewalA theme 8 companies write about · 0 as a headwind · 8 as a tailwind

The whole theme swung hardest in 2019: 1 of 6 companies on the "Worse" side.

4 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The total capital expenditures made by the group during the consolidated fiscal year were ¥465 million, mainly for the development of the next-generation core system at the filing company.」

    Capital expenditures totaled ¥465 million, with the main investment specifically identified as the development of the next-generation core system.
  2. FY2025¥640 million in capital expenditures and a change in investment focusAnnual report

    「The total capital expenditures made by the group during the consolidated fiscal year were ¥640 million, mainly for the renewal of leased assets at the filing company's Osaka head office.」

    Full-year capital expenditures totaled ¥640 million, down from ¥658 million in the previous fiscal year. The main investment was the renewal of leased assets at the Osaka head office.
  3. FY2024¥658 million in capital expenditures and a change in investment focusAnnual report

    「The total capital expenditures made by the group during the consolidated fiscal year were ¥658 million, mainly for the renovation of structures at a subsidiary.」

    Full-year capital expenditures totaled ¥658 million, with the main investment being the renovation of structures at a subsidiary.
  4. FY2023-Q2Lower Capital ExpenditureAnnual report

    「As a result of investing activities, funds decreased by ¥90 million (compared with a decrease of ¥1,330 million in the same quarter of the previous year). This was mainly due to ¥112 million in expenditures for the acquisition of property, plant and equipment.」

    Expenditures for the acquisition of property, plant and equipment were ¥112 million, down from ¥1,173 million in the same period of the previous year.
  5. FY2022-Q2AdvancedAnnual report

    「As a result of investing activities, funds decreased by ¥1,330 million (compared with a decrease of ¥979 million in the same quarter of the previous year). This was mainly due to ¥1,173 million in expenditures for the acquisition of property, plant and equipment. At the Kyoto R&D Center, which opened in May this year, the company is developing biomass plasticizers and 100% plant-derived ester oils to strengthen its approach to environmental issues.」

    Expenditures for the acquisition of property, plant and equipment totaled ¥1,173 million, and the Kyoto R&D Center opened in May.
  6. FY2021-Q2RestatedAnnual report

    「As a result of investing activities, funds decreased by ¥979 million (compared with a decrease of ¥564 million in the same quarter of the previous year). This was mainly due to ¥964 million in expenditures for the acquisition of property, plant and equipment.」

    The company spent ¥964 million on the acquisition of property, plant and equipment, continuing its capital expenditures.
  7. FY2020AdvancedAnnual report

    「The total capital expenditures made by the group during the consolidated fiscal year were ¥1,120 million, mainly for the construction of a new research facility, the Kyoto R&D Center, at the filing company.」

    Capital expenditures increased to ¥1,120 million, with the main investment progressing from the renewal of existing facilities to the construction of the Kyoto R&D Center. The Kyoto R&D Center was scheduled for completion in March 2021 and to begin operations in May 2021.
  8. FY2020-Q2RestatedAnnual report

    「As a result of investing activities, funds decreased by ¥564 million (compared with a decrease of ¥477 million in the same quarter of the previous year). This was mainly due to ¥609 million in expenditures for the acquisition of property, plant and equipment.」

    The company spent ¥609 million on the acquisition of property, plant and equipment, continuing its capital expenditures.
  9. FY2019-Q2RestatedAnnual report

    「As a result of investing activities, funds decreased by ¥477 million (compared with a decrease of ¥404 million in the same quarter of the previous year). This was mainly due to ¥616 million in expenditures for the acquisition of property, plant and equipment.」

    The company spent ¥616 million on the acquisition of property, plant and equipment during the six-month period, continuing its capital expenditures.
  10. FY2018AdvancedAnnual report

    「The total capital expenditures made by the group during the consolidated fiscal year were ¥724 million, mainly for the expansion of manufacturing facilities at the filing company.」

    Capital expenditures totaled ¥724 million, with the main investment shifting from the renewal of existing facilities to the expansion of manufacturing facilities.
  11. FY2018-Q2RestatedAnnual report

    「As a result of investing activities, funds decreased by ¥404 million (compared with an increase of ¥136 million in the same quarter of the previous year). This was mainly due to ¥298 million in expenditures for the acquisition of property, plant and equipment.」

    The company spent ¥298 million on the acquisition of property, plant and equipment during the six-month period, continuing its capital expenditures.
  12. FY2017First statedAnnual report

    「Capital expenditures for the consolidated fiscal year totaled ¥483 million. The main capital expenditures were for the renewal of substation equipment at the filing company.」

    Full-year capital expenditures totaled ¥483 million, and the renewal of substation equipment in the Chemical Products segment has been disclosed specifically for the first time.
Moved together

"Product development using proprietary technologies, including hydrogenation technology" moved the same way as this thread, in the same document, in 4 of its 12 moves.

433333★123456
  1. ★This thread
  2. 1Product development using proprietary technologies, including hydrogenation technology4×
  3. 2Ongoing Research and Development Activities3×
  4. 3Developing and commercialising new products that address market needs3×
  5. 4Increasing overseas sales and expanding market share3×
  6. 5Development of 3 high-performance, environmentally friendly plasticizer grades3×
  7. 6Expansion into performance chemicals3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
New Japan Chemical's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.